companydata.dkcompanydata.dk

Nordic Stem Cell Clinic ApS: Financial statements 2024

CVR: 44048434

Source: annual report 2024, Danish Business Authority

01/01/2024 – 31/12/2024

Nordic Stem Cell Clinic ApS (CVR 44048434) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK -264,713 and a net result of DKK -264,713. Equity in the 2024 report amounted to DKK 838,543. The solvency ratio was 19.2%.

Gross Profit
DKK -264,713
Profit/Loss
DKK -264,713
Equity
DKK 838,543
Total Assets
DKK 4,375,930

Official annual report

View the official annual report directly on the page with a Pro subscription.

Screen every Danish company

Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.

Try company screening

Events in 2024

Nordic Stem Cell Clinic ApS publishes interim reportJul 12, 2024

Nordic Stem Cell Clinic ApS has published its interim report for the period May 9, 2023 to December 31, 2023.

Blue Cell Clinics ApS changes name to Nordic Stem Cell Clinic ApSFeb 7, 2024

On February 7, 2024, the company changed its name from Blue Cell Clinics ApS to Nordic Stem Cell Clinic ApS.

About Nordic Stem Cell Clinic ApS

Nordic Stem Cell Clinic ApS is a Danish company of the type Anpartsselskab based in Klampenborg, founded in 2023. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named Blue Cell Clinics ApS. The management consists of Søren Paludan Sheikh. The company is owned by ANDRÉ ROGACZEWSKI HOLDING II ApS, SPSheikh Holding ApS and Ulveman Invest ApS. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -68,935 and a net result of DKK -4,310,487 compared with DKK -264,713 the year before. Equity in the 2025 report amounted to DKK -3,471,944.

Source: annual report 2025, Danish Business Authority

Other financial years